

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.38295768 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.79362886 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.65887598 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.63798817 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.47395866 |
| 6 | vocalization behavior (GO:0071625) | 5.43921575 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.33442235 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.21067037 |
| 9 | glutamate secretion (GO:0014047) | 5.18501230 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.09372791 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.03776891 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.95546349 |
| 13 | cerebellar granule cell differentiation (GO:0021707) | 4.85108441 |
| 14 | * regulation of glutamate receptor signaling pathway (GO:1900449) | 4.81009634 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.80859049 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.59310727 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.57706437 |
| 18 | glutamate receptor signaling pathway (GO:0007215) | 4.51774086 |
| 19 | protein localization to synapse (GO:0035418) | 4.51164072 |
| 20 | exploration behavior (GO:0035640) | 4.46925051 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.45105756 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.42562526 |
| 23 | * regulation of neuronal synaptic plasticity (GO:0048168) | 4.41570092 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 4.29580700 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.19738967 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.18688393 |
| 27 | neuromuscular process controlling posture (GO:0050884) | 4.18320725 |
| 28 | * regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.18209519 |
| 29 | potassium ion homeostasis (GO:0055075) | 4.17591824 |
| 30 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.12466051 |
| 31 | amino acid import (GO:0043090) | 4.12040347 |
| 32 | gamma-aminobutyric acid transport (GO:0015812) | 4.11043030 |
| 33 | potassium ion import (GO:0010107) | 4.00724481 |
| 34 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.00326041 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.90710648 |
| 36 | cellular potassium ion homeostasis (GO:0030007) | 3.90250686 |
| 37 | positive regulation of membrane potential (GO:0045838) | 3.88063749 |
| 38 | * long-term memory (GO:0007616) | 3.80245485 |
| 39 | neurotransmitter transport (GO:0006836) | 3.79623665 |
| 40 | axon ensheathment in central nervous system (GO:0032291) | 3.78977640 |
| 41 | central nervous system myelination (GO:0022010) | 3.78977640 |
| 42 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.77605190 |
| 43 | regulation of ARF protein signal transduction (GO:0032012) | 3.76951972 |
| 44 | proline transport (GO:0015824) | 3.76122735 |
| 45 | regulation of synapse structural plasticity (GO:0051823) | 3.75688474 |
| 46 | regulation of postsynaptic membrane potential (GO:0060078) | 3.73803966 |
| 47 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.72661169 |
| 48 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.70753808 |
| 49 | positive regulation of dendritic spine development (GO:0060999) | 3.69770383 |
| 50 | * regulation of synaptic plasticity (GO:0048167) | 3.65960433 |
| 51 | long-term synaptic potentiation (GO:0060291) | 3.65490876 |
| 52 | dendritic spine morphogenesis (GO:0060997) | 3.64237547 |
| 53 | regulation of synapse maturation (GO:0090128) | 3.60830561 |
| 54 | cellular sodium ion homeostasis (GO:0006883) | 3.57547611 |
| 55 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.57381766 |
| 56 | activation of protein kinase A activity (GO:0034199) | 3.55966242 |
| 57 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.54814263 |
| 58 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.54418151 |
| 59 | transmission of nerve impulse (GO:0019226) | 3.53992000 |
| 60 | regulation of neurotransmitter levels (GO:0001505) | 3.50137021 |
| 61 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.49071981 |
| 62 | sodium ion export (GO:0071436) | 3.48044029 |
| 63 | synaptic vesicle endocytosis (GO:0048488) | 3.46625502 |
| 64 | positive regulation of synapse maturation (GO:0090129) | 3.45703802 |
| 65 | startle response (GO:0001964) | 3.44606541 |
| 66 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.42947659 |
| 67 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.41758827 |
| 68 | postsynaptic membrane organization (GO:0001941) | 3.41184632 |
| 69 | regulation of dendritic spine development (GO:0060998) | 3.40611448 |
| 70 | membrane depolarization during action potential (GO:0086010) | 3.37799192 |
| 71 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.37047433 |
| 72 | regulation of neurotransmitter secretion (GO:0046928) | 3.36891130 |
| 73 | regulation of vesicle fusion (GO:0031338) | 3.36223304 |
| 74 | behavioral fear response (GO:0001662) | 3.35283568 |
| 75 | behavioral defense response (GO:0002209) | 3.35283568 |
| 76 | response to histamine (GO:0034776) | 3.34478080 |
| 77 | neuron recognition (GO:0008038) | 3.34424237 |
| 78 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.33770176 |
| 79 | presynaptic membrane assembly (GO:0097105) | 3.32792337 |
| 80 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.29638308 |
| 81 | cell communication by electrical coupling (GO:0010644) | 3.27733258 |
| 82 | glycine transport (GO:0015816) | 3.27245019 |
| 83 | neuromuscular process controlling balance (GO:0050885) | 3.27048636 |
| 84 | membrane depolarization (GO:0051899) | 3.25641872 |
| 85 | vesicle docking involved in exocytosis (GO:0006904) | 3.24805941 |
| 86 | regulation of exocytosis (GO:0017157) | 3.24524155 |
| 87 | layer formation in cerebral cortex (GO:0021819) | 3.24216759 |
| 88 | signal release (GO:0023061) | 3.22928537 |
| 89 | neurotransmitter uptake (GO:0001504) | 3.21851577 |
| 90 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.21223768 |
| 91 | chemosensory behavior (GO:0007635) | 3.21098869 |
| 92 | acidic amino acid transport (GO:0015800) | 3.19159601 |
| 93 | neuronal ion channel clustering (GO:0045161) | 3.17446793 |
| 94 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.16390463 |
| 95 | fear response (GO:0042596) | 3.16233765 |
| 96 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.14491485 |
| 97 | vesicle transport along microtubule (GO:0047496) | 3.14423100 |
| 98 | establishment of synaptic vesicle localization (GO:0097480) | 3.14345797 |
| 99 | synaptic vesicle transport (GO:0048489) | 3.14345797 |
| 100 | cerebellar Purkinje cell layer development (GO:0021680) | 3.13749783 |
| 101 | presynaptic membrane organization (GO:0097090) | 3.13590633 |
| 102 | regulation of neurotransmitter transport (GO:0051588) | 3.13436222 |
| 103 | membrane hyperpolarization (GO:0060081) | 3.12535958 |
| 104 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.12501450 |
| 105 | L-amino acid import (GO:0043092) | 3.12120647 |
| 106 | learning (GO:0007612) | 3.11534410 |
| 107 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.10301746 |
| 108 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.09405020 |
| 109 | * regulation of synaptic transmission (GO:0050804) | 3.08582711 |
| 110 | positive regulation of synaptic transmission (GO:0050806) | 3.08142983 |
| 111 | * synaptic transmission (GO:0007268) | 3.06370174 |
| 112 | axonal fasciculation (GO:0007413) | 3.05989401 |
| 113 | neuromuscular synaptic transmission (GO:0007274) | 3.05542390 |
| 114 | innervation (GO:0060384) | 3.04008598 |
| 115 | neuromuscular process (GO:0050905) | 3.03466783 |
| 116 | positive regulation of neurotransmitter transport (GO:0051590) | 3.03461158 |
| 117 | auditory behavior (GO:0031223) | 3.03033906 |
| 118 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.02995575 |
| 119 | serotonin metabolic process (GO:0042428) | 3.02827070 |
| 120 | cell differentiation in hindbrain (GO:0021533) | 3.02658153 |
| 121 | response to auditory stimulus (GO:0010996) | 3.01285972 |
| 122 | vesicle docking (GO:0048278) | 3.00606343 |
| 123 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.98803903 |
| 124 | dendritic spine organization (GO:0097061) | 2.98772949 |
| 125 | detection of calcium ion (GO:0005513) | 2.95335935 |
| 126 | intraspecies interaction between organisms (GO:0051703) | 2.95074307 |
| 127 | social behavior (GO:0035176) | 2.95074307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.31486093 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.85310072 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10023739 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01815108 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95255038 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.83396289 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.61493091 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60771421 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.60588491 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.60588491 |
| 11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57908933 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.57114737 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.51901873 |
| 14 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48503753 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47967927 |
| 16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40022356 |
| 17 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36432362 |
| 18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.30936267 |
| 19 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.26952493 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.24906508 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20718659 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19488512 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.10228582 |
| 24 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10070912 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.97487561 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.93450786 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88738758 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85804206 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83346401 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81152029 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77785136 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73969435 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68392079 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67939001 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60185449 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.57485402 |
| 37 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48265814 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42950465 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42227812 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.40564648 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40523366 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39912097 |
| 43 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32847933 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32732217 |
| 45 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32546347 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32234411 |
| 47 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.30074173 |
| 48 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.28351763 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27755071 |
| 50 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.27550870 |
| 51 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27440556 |
| 52 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22854184 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21057192 |
| 54 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.20635850 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19876157 |
| 56 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19431115 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19222408 |
| 58 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19153721 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18874628 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18654360 |
| 61 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.16759114 |
| 62 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16469448 |
| 63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16038780 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15593170 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14802212 |
| 66 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13663791 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11509142 |
| 68 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10843307 |
| 69 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09751859 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08089424 |
| 71 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07259683 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06651258 |
| 73 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03689641 |
| 74 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03182523 |
| 75 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03105315 |
| 76 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02521452 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02384724 |
| 78 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01938449 |
| 79 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01713616 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01263190 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01087887 |
| 82 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00269008 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99936418 |
| 84 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98720314 |
| 85 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98639900 |
| 86 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97387133 |
| 87 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95143773 |
| 88 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94129936 |
| 89 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94114653 |
| 90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93083644 |
| 91 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93009442 |
| 92 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92818743 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92301633 |
| 94 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92075871 |
| 95 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90916692 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89889493 |
| 97 | FUS_26573619_Chip-Seq_HEK293_Human | 0.89482445 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89395459 |
| 99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.89333213 |
| 100 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88970164 |
| 101 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.88880247 |
| 102 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88648936 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88383567 |
| 104 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88138602 |
| 105 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87487294 |
| 106 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86019740 |
| 107 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85882031 |
| 108 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85682555 |
| 109 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85493929 |
| 110 | JUN_21703547_ChIP-Seq_K562_Human | 0.85027831 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84733668 |
| 112 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.84212760 |
| 113 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83268423 |
| 114 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81422656 |
| 115 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.80616824 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79468231 |
| 117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78992085 |
| 118 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.78543401 |
| 119 | KDM2B_26808549_Chip-Seq_REH_Human | 0.78113175 |
| 120 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.77215903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0004859_abnormal_synaptic_plasticity | 6.44322658 |
| 2 | MP0003880_abnormal_central_pattern | 5.09602366 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.28621999 |
| 4 | MP0009745_abnormal_behavioral_response | 3.65236106 |
| 5 | MP0004270_analgesia | 3.56151526 |
| 6 | MP0002064_seizures | 3.40630967 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.35114991 |
| 8 | MP0009046_muscle_twitch | 3.32104545 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.99211614 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.91846354 |
| 11 | MP0002822_catalepsy | 2.86692854 |
| 12 | MP0002272_abnormal_nervous_system | 2.81618177 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.75856041 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.72727901 |
| 15 | MP0001486_abnormal_startle_reflex | 2.59842367 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.49357645 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.23056236 |
| 18 | MP0002736_abnormal_nociception_after | 2.20414386 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.18138762 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.12983015 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.02116665 |
| 22 | MP0002909_abnormal_adrenal_gland | 2.01317316 |
| 23 | MP0008569_lethality_at_weaning | 1.93342635 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.92374521 |
| 25 | MP0001970_abnormal_pain_threshold | 1.89925250 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 1.77007445 |
| 27 | MP0002557_abnormal_social/conspecific_i | 1.77002471 |
| 28 | MP0006276_abnormal_autonomic_nervous | 1.76707960 |
| 29 | MP0003879_abnormal_hair_cell | 1.69987071 |
| 30 | MP0004924_abnormal_behavior | 1.65729873 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.65729873 |
| 32 | MP0002184_abnormal_innervation | 1.65468720 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.64444174 |
| 34 | MP0003329_amyloid_beta_deposits | 1.60133748 |
| 35 | * MP0005646_abnormal_pituitary_gland | 1.50988008 |
| 36 | MP0004142_abnormal_muscle_tone | 1.49908539 |
| 37 | MP0001984_abnormal_olfaction | 1.47336035 |
| 38 | MP0002066_abnormal_motor_capabilities/c | 1.43772565 |
| 39 | MP0000778_abnormal_nervous_system | 1.43103847 |
| 40 | MP0000955_abnormal_spinal_cord | 1.42894447 |
| 41 | MP0004858_abnormal_nervous_system | 1.42323930 |
| 42 | MP0001502_abnormal_circadian_rhythm | 1.41372724 |
| 43 | MP0004885_abnormal_endolymph | 1.40163968 |
| 44 | MP0003633_abnormal_nervous_system | 1.38978467 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.36597845 |
| 46 | MP0001905_abnormal_dopamine_level | 1.33461840 |
| 47 | MP0001188_hyperpigmentation | 1.25607864 |
| 48 | MP0003283_abnormal_digestive_organ | 1.23326150 |
| 49 | MP0001529_abnormal_vocalization | 1.20895576 |
| 50 | MP0004147_increased_porphyrin_level | 1.19845978 |
| 51 | MP0003631_nervous_system_phenotype | 1.14481941 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.11130999 |
| 53 | MP0010386_abnormal_urinary_bladder | 1.09345505 |
| 54 | * MP0003122_maternal_imprinting | 1.03416019 |
| 55 | MP0004043_abnormal_pH_regulation | 1.01664494 |
| 56 | MP0002229_neurodegeneration | 1.01584482 |
| 57 | MP0002152_abnormal_brain_morphology | 1.00594242 |
| 58 | MP0002069_abnormal_eating/drinking_beha | 0.99832980 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 0.99030265 |
| 60 | MP0005535_abnormal_body_temperature | 0.98289494 |
| 61 | MP0000751_myopathy | 0.98164856 |
| 62 | MP0003690_abnormal_glial_cell | 0.96790578 |
| 63 | MP0008872_abnormal_physiological_respon | 0.93774380 |
| 64 | MP0002876_abnormal_thyroid_physiology | 0.92985758 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 0.92457966 |
| 66 | MP0001986_abnormal_taste_sensitivity | 0.91697501 |
| 67 | MP0001348_abnormal_lacrimal_gland | 0.89726398 |
| 68 | MP0008961_abnormal_basal_metabolism | 0.88839643 |
| 69 | MP0004085_abnormal_heartbeat | 0.88828613 |
| 70 | MP0001177_atelectasis | 0.88536571 |
| 71 | MP0008874_decreased_physiological_sensi | 0.88378247 |
| 72 | * MP0003787_abnormal_imprinting | 0.84323930 |
| 73 | MP0001963_abnormal_hearing_physiology | 0.84202486 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 0.83500219 |
| 75 | MP0003632_abnormal_nervous_system | 0.78633922 |
| 76 | MP0004742_abnormal_vestibular_system | 0.78441435 |
| 77 | MP0000569_abnormal_digit_pigmentation | 0.78255269 |
| 78 | MP0003634_abnormal_glial_cell | 0.77872895 |
| 79 | MP0000631_abnormal_neuroendocrine_gland | 0.77041893 |
| 80 | MP0003045_fibrosis | 0.74942268 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 0.74055561 |
| 82 | MP0001485_abnormal_pinna_reflex | 0.73777821 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.73746834 |
| 84 | MP0002638_abnormal_pupillary_reflex | 0.73659515 |
| 85 | MP0005499_abnormal_olfactory_system | 0.72477616 |
| 86 | MP0005394_taste/olfaction_phenotype | 0.72477616 |
| 87 | MP0000920_abnormal_myelination | 0.71979352 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.71525114 |
| 89 | MP0004215_abnormal_myocardial_fiber | 0.69455802 |
| 90 | MP0000639_abnormal_adrenal_gland | 0.66232875 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.65965420 |
| 92 | MP0002752_abnormal_somatic_nervous | 0.65259378 |
| 93 | MP0001664_abnormal_digestion | 0.64702433 |
| 94 | MP0001765_abnormal_ion_homeostasis | 0.63255810 |
| 95 | MP0000604_amyloidosis | 0.63136169 |
| 96 | MP0001346_abnormal_lacrimal_gland | 0.62760493 |
| 97 | MP0005409_darkened_coat_color | 0.61487231 |
| 98 | MP0004233_abnormal_muscle_weight | 0.59840057 |
| 99 | MP0004484_altered_response_of | 0.59392840 |
| 100 | MP0005171_absent_coat_pigmentation | 0.59311776 |
| 101 | * MP0003075_altered_response_to | 0.59145314 |
| 102 | MP0006072_abnormal_retinal_apoptosis | 0.59035305 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.57956681 |
| 104 | MP0001943_abnormal_respiration | 0.54889698 |
| 105 | MP0002090_abnormal_vision | 0.54533840 |
| 106 | MP0004510_myositis | 0.54506169 |
| 107 | MP0010769_abnormal_survival | 0.54403537 |
| 108 | MP0001299_abnormal_eye_distance/ | 0.53911854 |
| 109 | * MP0003956_abnormal_body_size | 0.53142293 |
| 110 | MP0005623_abnormal_meninges_morphology | 0.51949758 |
| 111 | MP0010768_mortality/aging | 0.51713689 |
| 112 | MP0002082_postnatal_lethality | 0.51571659 |
| 113 | MP0010770_preweaning_lethality | 0.51571659 |
| 114 | MP0005448_abnormal_energy_balance | 0.47167723 |
| 115 | MP0005379_endocrine/exocrine_gland_phen | 0.44916166 |
| 116 | MP0002693_abnormal_pancreas_physiology | 0.44418728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.80059182 |
| 2 | Myokymia (HP:0002411) | 6.60948075 |
| 3 | Focal seizures (HP:0007359) | 6.15045175 |
| 4 | Visual hallucinations (HP:0002367) | 5.43840698 |
| 5 | Atonic seizures (HP:0010819) | 5.18661571 |
| 6 | Epileptic encephalopathy (HP:0200134) | 5.13005217 |
| 7 | Febrile seizures (HP:0002373) | 4.99143561 |
| 8 | Absence seizures (HP:0002121) | 4.60120538 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.51970833 |
| 10 | Dialeptic seizures (HP:0011146) | 4.29285548 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.25796934 |
| 12 | Action tremor (HP:0002345) | 3.97830881 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.54171563 |
| 14 | Broad-based gait (HP:0002136) | 3.50882826 |
| 15 | Cerebral hypomyelination (HP:0006808) | 3.46527467 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.45831858 |
| 17 | Hyperventilation (HP:0002883) | 3.43254648 |
| 18 | Depression (HP:0000716) | 3.38839686 |
| 19 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.38779562 |
| 20 | Tetraplegia (HP:0002445) | 3.26935171 |
| 21 | Postural instability (HP:0002172) | 3.25573666 |
| 22 | Poor eye contact (HP:0000817) | 3.22621789 |
| 23 | Anxiety (HP:0000739) | 3.22435505 |
| 24 | Dysdiadochokinesis (HP:0002075) | 3.21572568 |
| 25 | Dysmetria (HP:0001310) | 3.21080572 |
| 26 | Truncal ataxia (HP:0002078) | 3.19038797 |
| 27 | Obstructive sleep apnea (HP:0002870) | 3.14487634 |
| 28 | Ankle clonus (HP:0011448) | 3.13006842 |
| 29 | Abnormal eating behavior (HP:0100738) | 3.10888024 |
| 30 | Akinesia (HP:0002304) | 3.05388155 |
| 31 | Abnormal social behavior (HP:0012433) | 2.97138326 |
| 32 | Impaired social interactions (HP:0000735) | 2.97138326 |
| 33 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.92287457 |
| 34 | Impaired smooth pursuit (HP:0007772) | 2.90088428 |
| 35 | Amblyopia (HP:0000646) | 2.86837342 |
| 36 | Genetic anticipation (HP:0003743) | 2.79618920 |
| 37 | Epileptiform EEG discharges (HP:0011182) | 2.75714616 |
| 38 | Abnormality of the lower motor neuron (HP:0002366) | 2.75226971 |
| 39 | Hemiplegia (HP:0002301) | 2.71163490 |
| 40 | Drooling (HP:0002307) | 2.68488680 |
| 41 | Excessive salivation (HP:0003781) | 2.68488680 |
| 42 | Papilledema (HP:0001085) | 2.64507694 |
| 43 | Apathy (HP:0000741) | 2.59922769 |
| 44 | Scanning speech (HP:0002168) | 2.58931128 |
| 45 | Hemiparesis (HP:0001269) | 2.58309351 |
| 46 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.57856628 |
| 47 | Bradykinesia (HP:0002067) | 2.57304393 |
| 48 | EEG with generalized epileptiform discharges (HP:0011198) | 2.53668155 |
| 49 | Progressive inability to walk (HP:0002505) | 2.52870304 |
| 50 | Mutism (HP:0002300) | 2.51938931 |
| 51 | Diplopia (HP:0000651) | 2.50410323 |
| 52 | Abnormality of binocular vision (HP:0011514) | 2.50410323 |
| 53 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.49390803 |
| 54 | Ventricular fibrillation (HP:0001663) | 2.49031487 |
| 55 | Status epilepticus (HP:0002133) | 2.44522560 |
| 56 | Hypsarrhythmia (HP:0002521) | 2.41393448 |
| 57 | Intention tremor (HP:0002080) | 2.40959823 |
| 58 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.38832922 |
| 59 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.38832922 |
| 60 | Spastic gait (HP:0002064) | 2.37250732 |
| 61 | Torticollis (HP:0000473) | 2.37239976 |
| 62 | Dysmetric saccades (HP:0000641) | 2.35767448 |
| 63 | Sleep apnea (HP:0010535) | 2.35384575 |
| 64 | Diminished motivation (HP:0000745) | 2.33200116 |
| 65 | Agitation (HP:0000713) | 2.32452898 |
| 66 | Impaired vibratory sensation (HP:0002495) | 2.31258577 |
| 67 | Absent speech (HP:0001344) | 2.30816660 |
| 68 | Increased circulating renin level (HP:0000848) | 2.28768285 |
| 69 | Choreoathetosis (HP:0001266) | 2.26609551 |
| 70 | Focal dystonia (HP:0004373) | 2.26302727 |
| 71 | Urinary urgency (HP:0000012) | 2.25992903 |
| 72 | Spastic tetraparesis (HP:0001285) | 2.25274541 |
| 73 | Stereotypic behavior (HP:0000733) | 2.23673194 |
| 74 | Decreased circulating renin level (HP:0003351) | 2.22780766 |
| 75 | CNS hypomyelination (HP:0003429) | 2.22567921 |
| 76 | Pheochromocytoma (HP:0002666) | 2.21911373 |
| 77 | Peripheral hypomyelination (HP:0007182) | 2.13156803 |
| 78 | Generalized myoclonic seizures (HP:0002123) | 2.12313512 |
| 79 | Blue irides (HP:0000635) | 2.10336226 |
| 80 | Polyphagia (HP:0002591) | 2.07212727 |
| 81 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.06470334 |
| 82 | Psychosis (HP:0000709) | 2.05050931 |
| 83 | Fetal akinesia sequence (HP:0001989) | 2.02387309 |
| 84 | Protruding tongue (HP:0010808) | 2.01136228 |
| 85 | Neurofibrillary tangles (HP:0002185) | 2.00458226 |
| 86 | Abnormal EKG (HP:0003115) | 1.99789221 |
| 87 | Lower limb muscle weakness (HP:0007340) | 1.99745826 |
| 88 | Gait ataxia (HP:0002066) | 1.97780091 |
| 89 | Lower limb asymmetry (HP:0100559) | 1.97205921 |
| 90 | Incomplete penetrance (HP:0003829) | 1.95861941 |
| 91 | Rapidly progressive (HP:0003678) | 1.95665428 |
| 92 | Cerebral inclusion bodies (HP:0100314) | 1.93797077 |
| 93 | Abnormality of saccadic eye movements (HP:0000570) | 1.93095760 |
| 94 | Inability to walk (HP:0002540) | 1.92328194 |
| 95 | Craniofacial dystonia (HP:0012179) | 1.92269486 |
| 96 | Hypoglycemic seizures (HP:0002173) | 1.91795013 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.91468527 |
| 98 | Neuronal loss in central nervous system (HP:0002529) | 1.88696387 |
| 99 | Failure to thrive in infancy (HP:0001531) | 1.88083057 |
| 100 | Diminished movement (HP:0002374) | 1.86675456 |
| 101 | Neuroendocrine neoplasm (HP:0100634) | 1.85655025 |
| 102 | Megalencephaly (HP:0001355) | 1.85349337 |
| 103 | Annular pancreas (HP:0001734) | 1.83683331 |
| 104 | Abnormality of salivation (HP:0100755) | 1.83333053 |
| 105 | Resting tremor (HP:0002322) | 1.82724473 |
| 106 | Memory impairment (HP:0002354) | 1.82344427 |
| 107 | Rigidity (HP:0002063) | 1.80789228 |
| 108 | Bundle branch block (HP:0011710) | 1.79272331 |
| 109 | Pointed chin (HP:0000307) | 1.73954189 |
| 110 | Clonus (HP:0002169) | 1.73573318 |
| 111 | Specific learning disability (HP:0001328) | 1.73555951 |
| 112 | Ocular albinism (HP:0001107) | 1.73450898 |
| 113 | Unsteady gait (HP:0002317) | 1.73394548 |
| 114 | Postural tremor (HP:0002174) | 1.72586119 |
| 115 | Abnormality of the corticospinal tract (HP:0002492) | 1.71509316 |
| 116 | Gait imbalance (HP:0002141) | 1.70052505 |
| 117 | Insomnia (HP:0100785) | 1.70048670 |
| 118 | Delusions (HP:0000746) | 1.68498551 |
| 119 | Spinal canal stenosis (HP:0003416) | 1.66241151 |
| 120 | Limb dystonia (HP:0002451) | 1.65311910 |
| 121 | Hypoventilation (HP:0002791) | 1.64225480 |
| 122 | Limb ataxia (HP:0002070) | 1.64187668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * NTRK3 | 4.53610523 |
| 2 | EPHA4 | 4.50319003 |
| 3 | MAP3K9 | 3.58819657 |
| 4 | MAP3K4 | 3.11963219 |
| 5 | MAP2K7 | 2.68436585 |
| 6 | MINK1 | 2.42852552 |
| 7 | CASK | 2.40844184 |
| 8 | MAP3K12 | 2.30051604 |
| 9 | DAPK2 | 2.24344251 |
| 10 | PRKD3 | 2.19573061 |
| 11 | PAK6 | 2.09747068 |
| 12 | NTRK2 | 2.05827850 |
| 13 | MAP2K4 | 1.95070057 |
| 14 | RIPK4 | 1.93258297 |
| 15 | TNIK | 1.91094721 |
| 16 | KSR2 | 1.88705877 |
| 17 | MARK1 | 1.86650374 |
| 18 | PRPF4B | 1.77993523 |
| 19 | CAMKK1 | 1.74354158 |
| 20 | DAPK1 | 1.64022605 |
| 21 | NTRK1 | 1.59966258 |
| 22 | STK38 | 1.59267785 |
| 23 | ARAF | 1.56077944 |
| 24 | MAP3K13 | 1.54242436 |
| 25 | CDK19 | 1.52404526 |
| 26 | FES | 1.49473319 |
| 27 | * CDK5 | 1.45051707 |
| 28 | KSR1 | 1.43987095 |
| 29 | PLK2 | 1.42095572 |
| 30 | GRK5 | 1.38817501 |
| 31 | PRKCG | 1.36549182 |
| 32 | RIPK1 | 1.34407815 |
| 33 | MAPK13 | 1.23002188 |
| 34 | MAP3K2 | 1.19648659 |
| 35 | UHMK1 | 1.17269425 |
| 36 | CAMK2A | 1.15763174 |
| 37 | CAMKK2 | 1.14208178 |
| 38 | FGFR2 | 1.13377674 |
| 39 | SGK223 | 1.10711632 |
| 40 | SGK494 | 1.10711632 |
| 41 | CAMK1 | 1.09846433 |
| 42 | PNCK | 1.07605204 |
| 43 | PRKCH | 1.06965599 |
| 44 | CAMK2B | 1.06708597 |
| 45 | SGK2 | 1.06202078 |
| 46 | SIK2 | 0.97654315 |
| 47 | PINK1 | 0.97317718 |
| 48 | AKT3 | 0.96174071 |
| 49 | FRK | 0.95601342 |
| 50 | TNK2 | 0.91507870 |
| 51 | SGK3 | 0.89526801 |
| 52 | BMPR2 | 0.88091246 |
| 53 | OXSR1 | 0.85924741 |
| 54 | PTK2B | 0.85308737 |
| 55 | MAPK12 | 0.84679893 |
| 56 | MAP3K1 | 0.83300031 |
| 57 | STK11 | 0.80749271 |
| 58 | SGK1 | 0.79738357 |
| 59 | CDK18 | 0.79620982 |
| 60 | CDC42BPA | 0.79337260 |
| 61 | TYRO3 | 0.77295609 |
| 62 | CDK15 | 0.76923692 |
| 63 | TAOK1 | 0.76087659 |
| 64 | INSRR | 0.76059233 |
| 65 | PAK3 | 0.76032345 |
| 66 | NEK6 | 0.74185158 |
| 67 | RAF1 | 0.72303697 |
| 68 | CDK14 | 0.71704542 |
| 69 | PDK1 | 0.69520880 |
| 70 | FER | 0.67578341 |
| 71 | LIMK1 | 0.67534275 |
| 72 | CDK11A | 0.66204282 |
| 73 | DAPK3 | 0.65476085 |
| 74 | NME1 | 0.64908986 |
| 75 | PKN1 | 0.64591990 |
| 76 | PDPK1 | 0.64307208 |
| 77 | CAMK2D | 0.63413943 |
| 78 | ALK | 0.63021000 |
| 79 | CAMK2G | 0.61678463 |
| 80 | MARK2 | 0.61513130 |
| 81 | PRKCE | 0.60501608 |
| 82 | BRAF | 0.60219426 |
| 83 | LMTK2 | 0.59470355 |
| 84 | DYRK1A | 0.59382205 |
| 85 | RET | 0.58017779 |
| 86 | WNK1 | 0.56280309 |
| 87 | RPS6KA3 | 0.55634212 |
| 88 | MAP2K6 | 0.55527363 |
| 89 | PHKG1 | 0.53374661 |
| 90 | PHKG2 | 0.53374661 |
| 91 | SIK3 | 0.52781093 |
| 92 | MAP3K7 | 0.52281798 |
| 93 | ROCK2 | 0.51437869 |
| 94 | TESK1 | 0.50834694 |
| 95 | CSNK1G2 | 0.47428690 |
| 96 | MAPK10 | 0.47354325 |
| 97 | WNK3 | 0.47289438 |
| 98 | CAMK1G | 0.45611825 |
| 99 | CAMK4 | 0.43696092 |
| 100 | LATS2 | 0.42478583 |
| 101 | FYN | 0.41006251 |
| 102 | IRAK2 | 0.40464165 |
| 103 | MUSK | 0.39312272 |
| 104 | PRKD2 | 0.39056321 |
| 105 | PRKCA | 0.38289222 |
| 106 | CCNB1 | 0.38257548 |
| 107 | PRKCZ | 0.37571003 |
| 108 | BRSK1 | 0.36710841 |
| 109 | PRKCB | 0.36693882 |
| 110 | MAP2K1 | 0.34881956 |
| 111 | PRKG1 | 0.33914747 |
| 112 | ROCK1 | 0.32557524 |
| 113 | CSNK1A1 | 0.31882605 |
| 114 | * PRKACA | 0.31485741 |
| 115 | MAP3K11 | 0.31406568 |
| 116 | CSNK1D | 0.29860893 |
| 117 | PRKG2 | 0.27651205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.03091513 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.39715302 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.88356017 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.83625029 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.76880077 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.76826693 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.70725582 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.64080065 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.62946825 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.58363793 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.34779306 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.21276378 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.19003439 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.14107360 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.97151660 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.92019662 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.88154630 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.84113164 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.78582767 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.76194470 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.75365749 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.68979388 |
| 23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.67912582 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.66822426 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.63699203 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.59417227 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56528619 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49457508 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41461207 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.40316346 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.39686597 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32824114 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24459528 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22821876 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20383835 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20254687 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.19452304 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.18118096 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08983111 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01840448 |
| 41 | Glioma_Homo sapiens_hsa05214 | 0.97700152 |
| 42 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.97489485 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95392944 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 0.95119091 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91823936 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91382128 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.89855261 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89036463 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87953502 |
| 50 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85634687 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85451098 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 0.82417570 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80226759 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78932057 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77676480 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76357750 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 0.74305795 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73306911 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72185444 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69735524 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67223790 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65483105 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65391400 |
| 64 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63491967 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61757293 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59218702 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54065608 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51006296 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49990363 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49170290 |
| 71 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.48244854 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47921570 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.47653632 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47527932 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45698186 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.45210309 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45037435 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.44591854 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43244576 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42701981 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40494928 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40070701 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38854401 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37477617 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.37059316 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36848637 |
| 87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.36053821 |
| 88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35355421 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34800166 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34446098 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33854293 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33217028 |
| 93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33145027 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31802064 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31761740 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31560359 |
| 97 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31367909 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30504055 |
| 99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28800947 |
| 100 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28138016 |
| 101 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28065334 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28006855 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.28003303 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27543572 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26612729 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26541543 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26464311 |
| 108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24901818 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24787775 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21075106 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.19646954 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.17000442 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.13581245 |

